There are currently 297 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Autism participants are California, Texas, New York and Florida.
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Recruiting
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Gender:
All
Ages:
18 years and above
Trial Updated:
09/14/2023
Locations: Ohio State University Wexner Medical Center, Columbus, Ohio
Conditions: Cancer
Enhancing Cancer Care Of Rural Dwellers
Recruiting
Through a multi-level remote intervention, the Vanderbilt-Ingram Cancer Center (VICC) seeks to improve comprehensive cancer care delivery to patients residing in rural communities with persistent poverty. We plan to do this by using telehealth to broaden the reach of our NCI-designated comprehensive cancer center in these communities
Gender:
All
Ages:
21 years and above
Trial Updated:
11/16/2023
Locations: Baptist Cancer Center- Golden Triangle Columbus, Columbus, Mississippi +4 locations
Conditions: Cancer
Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients
Recruiting
The purpose of this study is to learn whether an education and support program can help caregivers feel more confident in technical and communication skills needed to care for a person with cancer. Patients with cancer and their caregivers face many challenges. These include learning about cancer and its treatment, coping with symptoms from illness and treatment side effects, making adjustments to usual activities, and managing the emotional effects of having a serious illness. This study is tes... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/26/2023
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio +1 locations
Conditions: Cancer
A Pilot Feasibility Trial of a Tailored Intervention to Improve Adherence in Adolescents and Young Adults With Cancer
Recruiting
A pilot feasibility randomized clinical trial comparing a tailored intervention to uniform standard of care will be conducted. A total of 40 AYAs with cancer will be randomized to one of the two programs. Data will be collected to explore the hypotheses that the intervention meets pre-established enrollment, retention, fidelity, and data completion feasibility criteria and that AYAs will rate the intervention as easy to use and acceptable.
Gender:
All
Ages:
Between 15 years and 24 years
Trial Updated:
09/20/2023
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio +2 locations
Conditions: Cancer, Adherence, Medication
RISE (Reinvent, Integrate, Strengthen, Expand) Self-Management Program for Cancer Survivors: A Feasibility Study
Recruiting
This is a prospective feasibility study using a convenience sample of cancer survivors from Cedars-Sinai and its surrounding catchment area. As this study will be primarily focused on optimization of the RISE (Re-invent, Integrate, Strengthen, Expand) protocol, there will be no control group or randomization of participants. The RISE intervention is informed by the principles of Lifestyle Redesign, an occupational therapy-based therapeutic technique focused on measurable, individually-tailored,... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2024
Locations: Cedars-Sinai Medical Center, Los Angeles, California
Conditions: Cancer, Survivorship
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Recruiting
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2024
Locations: Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida +7 locations
Conditions: Endometrial Cancer, Endometrioid Tumor, Cancer, Tumor, Recurrent Endometrial Carcinoma, Endometrioid Endometrial Cancer
Education Tools to Support Pediatric Survivor Care
Recruiting
This study aims to evaluate the impact of electronic educational materials on adolescent and young adult ("AYA") survivors' knowledge about late effects, perceived benefits, self-efficacy, and intentions to engage in lifelong survivor care.
Gender:
All
Ages:
Between 18 years and 25 years
Trial Updated:
04/22/2024
Locations: Children's Healthcare of Atlanta, Atlanta, Georgia
Conditions: Cancer, Pediatric Cancer
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) FDG PET/CT for Malignant Lesion Detection
Recruiting
Fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) has been demonstrated to outperform other imaging modalities such as CT and magnetic resonance imaging (MRI) for the detection of metastatic cancers. Therefore, it is currently used for cancer staging, re-staging, and for monitoring response to therapy for many types of cancers. Despite its wide use and success, the diagnostic accuracy of FDG-PET/CT is suboptimal for lesions that are significantly smaller than 1... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/22/2024
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: Cancer
Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
Recruiting
This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/22/2024
Locations: University of California, San Francisco, San Francisco, California
Conditions: Cancer, Tobacco Dependence, Tobacco Use Cessation
Tumor Related Epilepsy
Recruiting
Background: Some people with brain tumors have seizures related to the tumor. This is called tumor-related epilepsy. Usually brain tumors are treated by removing as much of the brain tumor as possible without causing problems. Researchers think this may improve the outcome for people with brain tumors. It may completely relieve or greatly reduce the number of seizures they have. Objectives: To evaluate people with brain tumors that are associated with seizures and to offer surgical treatment.... Read More
Gender:
All
Ages:
Between 8 years and 99 years
Trial Updated:
04/20/2024
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland
Conditions: Epilepsy, Cancer, Brain Neoplasm
A Phase 2 Study of CRG-022 in Patients With Relapsed/Refractory Large B-cell Lymphoma
Recruiting
This is a prospective, open-label, multi-center clinical study designed to evaluate the safety, tolerability, efficacy, pharmacokinetics, pharmacodynamics, and immunogenicity of CRG-022, a CD22-directed autologous Chimeric Antigen Receptor (CAR) T-cell therapy for the treatment of relapsed or refractory large B-cell lymphoma (LBCL).
Gender:
All
Ages:
18 years and above
Trial Updated:
04/19/2024
Locations: University of Arkansas Medical Sciences, Little Rock, Arkansas +22 locations
Conditions: Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL)
Patient-Centered Assessment of Symptoms and Outcomes
Recruiting
Background: The cause of fatigue is not well understood. It can be felt differently by different people. Some people think there are different types of fatigue, with different causes. Researchers think a therapy to treat one type of fatigue in one condition should be able to treat that type of fatigue in other conditions. Objective: To understand the types of fatigue. Eligibility: Adults 18 and older who have felt fatigue for more than a month, and non-fatigued adults Design: Participants... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2024
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland
Conditions: Fatigue, Cancer, CFS, ME/CFS, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Lupus, Systemic Lupus Erthematosus, Sjogrens